TLR4 and prostate carcinoma: As shown in Fig. 2, serum‐free medium containing only 1% BSA supports the baseline surface expression of TLR4, and interaction with its natural ligand LPS, and appears to slightly upregulate its expression on the surfaces of adhered prostate cancer (PC3) cells.